Cargando…

Alternative activation generates IL-10 producing type 2 innate lymphoid cells

Type 2 innate lymphoid cells (ILC2) share cytokine and transcription factor expression with CD4(+) T(h)2 cells, but functional diversity of the ILC2 lineage has yet to be fully explored. Here, we show induction of a molecularly distinct subset of activated lung ILC2, termed ILC2(10). These cells pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Seehus, Corey R., Kadavallore, Asha, Torre, Brian de la, Yeckes, Alyson R., Wang, Yizhou, Tang, Jie, Kaye, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711851/
https://www.ncbi.nlm.nih.gov/pubmed/29196657
http://dx.doi.org/10.1038/s41467-017-02023-z
Descripción
Sumario:Type 2 innate lymphoid cells (ILC2) share cytokine and transcription factor expression with CD4(+) T(h)2 cells, but functional diversity of the ILC2 lineage has yet to be fully explored. Here, we show induction of a molecularly distinct subset of activated lung ILC2, termed ILC2(10). These cells produce IL-10 and downregulate some pro-inflammatory genes. Signals that generate ILC2(10) are distinct from those that induce IL-13 production, and gene expression data indicate that an alternative activation pathway leads to the generation of ILC2(10). In vivo, IL-2 enhances ILC2(10) generation and is associated with decreased eosinophil recruitment to the lung. Unlike most activated ILC2, the ILC2(10) population contracts after cessation of stimulation in vivo, with maintenance of a subset that can be recalled by restimulation, analogous to T-cell effector cell and memory cell generation. These data demonstrate the generation of a previously unappreciated IL-10 producing ILC2 effector cell population.